Study to Assess the Efficacy of Cognitex

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

August 31, 2009

Conditions
ElderlyMemory Impairment
Interventions
DIETARY_SUPPLEMENT

Cognitex

Treatment will consist of one capsule of Cognitex (Life Extension, USA), three times a day, with meals, delivering a total of 600 mg GPC, 100 mg PS-omega 3, 20 mg vinpocetine, 50 mg uridine-5'-monophosphate (disodium), 550 mg plant extracts (150 mg wild blueberry, 125 mg ashwagandha, 150 mg grape seed, 125 mg hops, ginger and rosemary). Duration: 15 weeks

Trial Locations (1)

Unknown

Suorasky Medical Center, Tel Aviv

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Enzymotec

INDUSTRY

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV